跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,027 条关于
“Shionogi & Co”
全部
12,027
临床试验
2,666
药物
1,025
机构
1,533
资讯
6,803
10个月前
Shionogi Completes Acquisition of Japan Tobacco's Pharmaceutical Business and Plans Manufacturing Subsidiary Merger
5个月前
Shionogi Completes $2.5 Billion Acquisition of RADICAVA for ALS Treatment, Expanding Rare Disease Portfolio
去年
Shionogi Submits Zuranolone NDA in Japan for Major Depressive Disorder
去年
Shionogi Secures Japan's First ADHD Digital Therapeutic Approval with ENDEAVORRIDE
11个月前
Genentech Launches Direct-to-Patient Program for Xofluza, Offering 70% Price Reduction
去年
Nxera Pharma Partners with Shionogi for Quviviq Distribution in Japan Following Approval for Insomnia
去年
FDA Grants Fast Track Designation to Shionogi's Novel Anti-RSV Drug Candidate S-337395
去年
Shionogi to Acquire Japan Tobacco's Pharmaceutical Subsidiaries for $1.1 Billion
去年
Shionogi and Osaka Metropolitan University Form Strategic Alliance to Combat Infectious Diseases
去年
Ensitrelvir Shows Promise as Post-Exposure Prophylaxis for COVID-19 in Phase 3 Trial
第 1 页,共 681 页
上一页
下一页